A study by Duke investigators into the activity of a brain receptor provides new clues for tackling obsessive behaviors in humans.
Dr. Nancy Andrews, dean of the School of Medicine and vice chancellor for academic affairs, will step down in June 2017, the University announced Friday. Andrews has served as dean since 2007.
Children’s early attention and social skills may soon be recognized as equally important as their early academic skills in facilitating scholastic success into young adulthood.
On the heels of announcing their partnership with Duke in January, representatives from the Indian Institute of Technology in Ghandinagar met with Duke officials in Durham last month to build upon their previous discussions.
Duke researchers are aiming to study marine landscapes from a new perspective—the sky. Drone technology has opened up many avenues for environmental scientists to study the movement, magnitude and health of marine species. Duke scientists have started using drones to do just that. David Johnston, assistant professor of the practice of marine conservation ecology, is currently implementing drones to study coastal waterways.
Duke investigators have successfully engineered a protein antibody that is capable of targeting cancerous tumors.
Duke researchers are making strides in understanding the basis of breast cancer relapse through bone marrow dormancy. The study–which was published last Wednesday in the journal Science Translational Medicine–was led by Dorothy Pipkins, associate professor in the division of hematological malignancies and cellular therapy, and employed high-resolution fluorescence microscopy in order to observe the migration of breast cancer cells in and out of bone marrow tissue.
A poliovirus cancer treatment designed by Duke medical researchers has been awarded rare breakthrough therapy status by the Food and Drug Administration last week to speed up its approval process for market use. The FDA recognition comes off the heels of Phase 1 clinical trials held at Duke Health’s Preston Robert Tisch Brain Tumor Center, where medical faculty found a 20% three-year survival rate in patients with glioblastoma–a particularly notorious form of brain cancer–compared to a historical 4% survival rate.
In the future, motivating yourself to write that final paper could start with hooking your brain up to a TV monitor.
Duke researchers are shedding light on the role skin cells play in influencing the body's response to external stimuli, opening up possibilities for new drugs to treat acute and chronic itches.
Duke professor Sheila Patek recently visited politicians in Washington to clarify misrepresentations of her research.
Duke scientists are developing technology that could be used to better detect methane leaks and hidden explosives, among other substances.
The Duke University Hospital will soon feature a program to address the unique needs of teenage cancer patients. Using donations from the Duke Cancer Institute and outside foundations, DUH is in the process of planning the program’s services and hopes to unveil it by the second half of this year, said Daniel Wechsler, a pediatric hematology-oncology specialist at DUH.
New research has called into question one of the most famous principles of German philosopher Immanuel Kant.
Researchers at Duke have been accused of withholding clinical data used to evaluate the blood thinner drug Xarelto.
Duke researchers have discovered an antibody that could help develop an HIV vaccine.
Duke researchers have engineered bacteria that cannot survive outside their colony, lowering the risk of contamination that normally accompanies genetically engineered microorganisms. One of the main risks of genetically manipulating organisms in a laboratory setting is the potential for the microorganism to escape from its regulated environment and multiply uncontrollably in the wild. Researchers at Duke have engineered a safeguard that would prevent microbes from surviving outside the confines of their enclosures.
Panelists discussed how to bridge the perceived gap between religion and climate change Wednesday. Katharine Hayhoe, director of the Climate Science Center at Texas Tech University, explained that opposition to believing in climate change is primarily a phenomenon of politics, not religion.
Professionals and students from across the country gathered at Duke Friday to discuss forming new alliances for promoting access to medicine. The conference - titled “Alliances and Incentives in the Era of Outbreaks” - brought in speakers from fields like policy, law and clinical research to discuss their opinions on global health and access as well as the Ebola vaccine.
Student teams presented proposals to combat the spread of the Zika virus Wednesday evening.
